Specialties
Sean Ronnekleiv-Kelly, MD, FACS
Associate Professor
- Endowed Professor, Ronald E. and Patricia A. Kissinger Surgical Oncology Research Professorship
- Division of Surgical Oncology
ronnekleiv-kelly@surgery.wisc.edu
- Administrative Assistant: (608) 262-2025
600 Highland Avenue
Clinical Science Center
Madison WI 53792-7375
Education
- MD, University of Colorado School of Medicine
- General Surgery Residency, University of Wisconsin School of Medicine and Public Health
- Complex General Surgical Oncology Fellowship, Johns Hopkins Hospital
Clinical Specialties
Certified by the American Board of Surgery in General Surgery and specializes in malignant disease of the pancreas, liver, gallbladder and biliary tree, stomach and small intestine, neuroendocrine tumors and retroperitoneal sarcoma.
Research Interests
Principal research interest is pancreatic cancer. My lab focuses on formation and progression of pancreatic cancer as well as understanding communication within the tumor microenvironment.
Dr. Sean Ronnekleiv-Kelly was awarded a two-year, $276,000 grant from the Fibrolamellar Cancer Foundation. Read more here.
Recent Publications
Understanding futility in pancreaticoduodenectomy: Insights from a national cohort.
Marcinak CT, Ahmed KS, LoConte NK, Praska CE, Varley PR, Weber SM, Abbott DE, Ronnekleiv-Kelly SM, Kratz JD, Lubner SJ, Minter RM, Zafar SN
J Surg Oncol 2024 Jul 31;
[PubMed ID: 39082628]Circadian disruption, clock genes, and metabolic health.
Schrader LA, Ronnekleiv-Kelly SM, Hogenesch JB, Bradfield CA, Malecki KM
J Clin Invest 2024 Jul 15; 134(14)
[PubMed ID: 39007272]Diverse mechanisms by which chemical pollutant exposure alters gut microbiota metabolism and inflammation.
Teffera M, Veith AC, Ronnekleiv-Kelly S, Bradfield CA, Nikodemova M, Tussing-Humphreys L, Malecki K
Environ Int 2024 Aug; 190: 108805
[PubMed ID: 38901183]Aryl Hydrocarbon Receptor Knockout Accelerates PanIN Formation and Fibro-Inflammation in a Mutant Kras -Driven Pancreatic Cancer Model.
Walcheck MT, Schwartz PB, Carrillo ND, Matkowskyj KA, Nukaya M, Bradfield CA, Ronnekleiv-Kelly SM
Pancreas 2024 Sep 01; 53(8): e670-e680
[PubMed ID: 38696422]DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma.
Ma RK, Tsai PY, Farghli AR, Shumway A, Kanke M, Gordan JD, Gujral TS, Vakili K, Nukaya M, Noetzli L, Ronnekleiv-Kelly S, Broom W, Barrow J, Sethupathy P
PLoS Genet 2024 Mar; 20(3): e1011216
[PubMed ID: 38512964]